Chimerna Therapeutics, Inc.
Biotechnology company · New York, United States
Chimerna Therapeutics, Inc. is a biotechnology company headquartered in New York, United States. It has received 8 US government small-business research awards (SBIR/STTR) from health agencies, $3.5 million in total, most recently in 2025.
Chimerna Therapeutics at a glance
What does Chimerna Therapeutics do?
US government research funding
8 SBIR/STTR small-business research awards from US health agencies, $3.5 million in total (2020 to 2025). NIH funding came from the National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, National Human Genome Research Institute.
Frequently asked questions about Chimerna Therapeutics
Where is Chimerna Therapeutics headquartered?
Chimerna Therapeutics, Inc. is headquartered in New York, United States.
What does Chimerna Therapeutics do?
Chimerna Therapeutics, Inc. is a biotechnology company.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences